Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 514

1.

Utility of 3D Printed Cardiac Models for Medical Student Education in Congenital Heart Disease: Across a Spectrum of Disease Severity.

Smerling J, Marboe CC, Lefkowitch JH, Pavlicova M, Bacha E, Einstein AJ, Naka Y, Glickstein J, Farooqi KM.

Pediatr Cardiol. 2019 Aug;40(6):1258-1265. doi: 10.1007/s00246-019-02146-8. Epub 2019 Jun 25.

PMID:
31240370
2.

Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.

Baba M, Yokoyama K, Seiriki K, Naka Y, Matsumura K, Kondo M, Yamamoto K, Hayashida M, Kasai A, Ago Y, Nagayasu K, Hayata-Takano A, Takahashi A, Yamaguchi S, Mori D, Ozaki N, Yamamoto T, Takuma K, Hashimoto R, Hashimoto H, Nakazawa T.

Neuropsychopharmacology. 2019 Jun 19. doi: 10.1038/s41386-019-0441-5. [Epub ahead of print]

PMID:
31216562
3.

Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.

Truby LK, Farr MA, Garan AR, Givens R, Restaino SW, Latif F, Takayama H, Naka Y, Takeda K, Topkara VK.

Circulation. 2019 Aug 6;140(6):459-469. doi: 10.1161/CIRCULATIONAHA.118.036932. Epub 2019 Jun 17.

PMID:
31203669
4.

Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation.

Han J, Pinsino A, Sanchez J, Takayama H, Garan AR, Topkara VK, Naka Y, Demmer RT, Kurlansky PA, Colombo PC, Takeda K, Yuzefpolskaya M.

J Heart Lung Transplant. 2019 May 24. pii: S1053-2498(19)31511-6. doi: 10.1016/j.healun.2019.05.007. [Epub ahead of print]

PMID:
31201088
5.

Effect of Socioeconomic Status on Patients Supported with Contemporary Left Ventricular Assist Devices.

Clemons AM, Flores RJ, Blum R, Wayda B, Brunjes DL, Habal M, Givens RC, Truby LK, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Farr MA, Naka Y, Colombo PC, Topkara VK.

ASAIO J. 2019 Jun 6. doi: 10.1097/MAT.0000000000001009. [Epub ahead of print]

PMID:
31192839
6.

Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation.

Cevasco M, Takayama H, Ando M, Garan AR, Naka Y, Takeda K.

J Thorac Dis. 2019 Apr;11(4):1676-1683. doi: 10.21037/jtd.2019.03.29. Review.

7.

Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.

Takeda K, Takayama H, Sanchez J, Cevasco M, Yuzefpolskaya M, Colombo PC, Naka Y.

Interact Cardiovasc Thorac Surg. 2019 May 29. pii: ivz113. doi: 10.1093/icvts/ivz113. [Epub ahead of print]

PMID:
31143932
8.

Outcomes of bridge to cardiac retransplantation in the contemporary mechanical circulatory support era.

Sanchez JE, Takayama H, Ando M, Han J, Kurlansky P, Garan AR, Topkara VK, Farr M, Colombo PC, Naka Y, Takeda K.

J Thorac Cardiovasc Surg. 2019 Jul;158(1):171-181.e1. doi: 10.1016/j.jtcvs.2019.01.135. Epub 2019 Feb 28.

PMID:
31097199
9.

Transcranial Doppler is an effective method in assessing cerebral blood flow patterns during peripheral venoarterial extracorporeal membrane oxygenation.

Salna M, Ikegami H, Willey JZ, Garan AR, Cevasco M, Chan C, Takayama H, Colombo PC, Naka Y, Takeda K.

J Card Surg. 2019 Jun;34(6):447-452. doi: 10.1111/jocs.14060. Epub 2019 May 6.

PMID:
31058374
10.

Whole-brain block-face serial microscopy tomography at subcellular resolution using FAST.

Seiriki K, Kasai A, Nakazawa T, Niu M, Naka Y, Tanuma M, Igarashi H, Yamaura K, Hayata-Takano A, Ago Y, Hashimoto H.

Nat Protoc. 2019 May;14(5):1509-1529. doi: 10.1038/s41596-019-0148-4. Epub 2019 Apr 8.

PMID:
30962606
11.

Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant.

DeRoo SC, Takayama H, Nemeth S, Garan AR, Kurlansky P, Restaino S, Colombo P, Farr M, Naka Y, Takeda K.

J Thorac Cardiovasc Surg. 2019 Feb 28. pii: S0022-5223(19)30512-4. doi: 10.1016/j.jtcvs.2019.02.065. [Epub ahead of print]

PMID:
30948318
12.

High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation.

Uriel N, Imamura T, Sayer G, Agarwal R, Sims DB, Takayama H, John R, Pagani FD, Naka Y, Sundareswaran KS, Farrar DJ, Jorde UP; Heartmate II Clinical Investigators.

J Card Fail. 2019 Mar 20. pii: S1071-9164(18)31147-3. doi: 10.1016/j.cardfail.2019.03.010. [Epub ahead of print]

PMID:
30904557
13.

A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.

Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ; MOMENTUM 3 Investigators.

N Engl J Med. 2019 Apr 25;380(17):1618-1627. doi: 10.1056/NEJMoa1900486. Epub 2019 Mar 17.

PMID:
30883052
14.

Midterm Outcomes of Bridge-to-Recovery Patients After Short-Term Mechanical Circulatory Support.

Cheng YT, Garan AR, Sanchez J, Kurlansky P, Ando M, Cevasco M, Yuzefpolskaya M, Colombo PC, Naka Y, Takayama H, Takeda K.

Ann Thorac Surg. 2019 Aug;108(2):524-530. doi: 10.1016/j.athoracsur.2019.01.060. Epub 2019 Mar 6.

PMID:
30851259
15.

Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.

DeFilippis EM, Truby LK, Garan AR, Givens RC, Takeda K, Takayama H, Naka Y, Haythe JH, Farr MA, Topkara VK.

JACC Heart Fail. 2019 Mar;7(3):250-257. doi: 10.1016/j.jchf.2019.01.008.

PMID:
30819381
16.

A Golgi-targeting fluorescent probe for labile Fe(ii) to reveal an abnormal cellular iron distribution induced by dysfunction of VPS35.

Hirayama T, Inden M, Tsuboi H, Niwa M, Uchida Y, Naka Y, Hozumi I, Nagasawa H.

Chem Sci. 2018 Nov 26;10(5):1514-1521. doi: 10.1039/c8sc04386h. eCollection 2019 Feb 7.

17.

The Validation of the Wheat Gluten ELISA Kit.

Saito E, Doi H, Kurihara K, Kato K, Aburatani K, Shoji M, Naka Y, Koerner T, Poepping B, Boison J.

J AOAC Int. 2019 Jul 1;102(4):1162-1173. doi: 10.5740/jaoacint.19-0005. Epub 2019 Feb 26.

PMID:
30808436
18.

Adverse Event Profile Associated with Prolonged Use of CentriMag Ventricular Assist Device for Refractory Cardiogenic Shock.

Cevasco MR, Li B, Han J, Chiuzan C, Mauro CM, Kurlansky P, Garan AR, Takeda K, Naka Y, Takayama H.

ASAIO J. 2019 Feb 20. doi: 10.1097/MAT.0000000000000893. [Epub ahead of print]

PMID:
30807379
19.

Palliative Care Consultation in Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Retrospective Cohort Study.

Nakagawa S, Garan AR, Takeda K, Takayama H, Topkara VK, Yuzefpolskaya M, Yuill L, Lin SX, Colombo PC, Naka Y, Blinderman CD.

J Palliat Med. 2019 Apr;22(4):432-436. doi: 10.1089/jpm.2018.0393. Epub 2019 Jan 7.

PMID:
30615561
20.

Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion.

Coromilas EJ, Takeda K, Ando M, Cevasco M, Green P, Karmpaliotis D, Kirtane A, Topkara VK, Yuzefpolskaya M, Takayama H, Naka Y, Burkhoff D, Colombo PC, Garan AR.

J Card Fail. 2019 Feb;25(2):105-113. doi: 10.1016/j.cardfail.2018.12.005. Epub 2018 Dec 22.

PMID:
30582967
21.

Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device.

Pinsino A, Castagna F, Zuver AM, Royzman EA, Nasiri M, Stöhr EJ, Cagliostro B, McDonnell B, Cockcroft JR, Garan AR, Topkara VK, Schulze PC, Takeda K, Takayama H, Naka Y, Demmer RT, Willey JZ, Yuzefpolskaya M, Colombo PC.

J Heart Lung Transplant. 2019 Apr;38(4):396-405. doi: 10.1016/j.healun.2018.11.003. Epub 2018 Nov 15.

PMID:
30559034
22.

Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage.

Allen KB, Icke KJ, Thourani VH, Naka Y, Grubb KJ, Grehan J, Patel N, Guy TS, Landolfo K, Gerdisch M, Bonnell M.

Ann Cardiothorac Surg. 2018 Sep;7(5):611-620. doi: 10.21037/acs.2018.06.01.

23.

Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants.

Henmi Y, Kakimoto K, Inoue T, Nakazawa K, Kubota M, Hara A, Mikami T, Naka Y, Hirata Y, Hirata Y, Sakanaka T, Nouda S, Okada T, Kawakami K, Takeuchi T, Tominaga K, Higuchi K.

J Clin Biochem Nutr. 2018 Nov;63(3):246-251. doi: 10.3164/jcbn.18-14. Epub 2018 Jun 8.

24.

Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry.

Truby LK, Garan AR, Givens RC, Wayda B, Takeda K, Yuzefpolskaya M, Colombo PC, Naka Y, Takayama H, Topkara VK.

JACC Heart Fail. 2018 Nov;6(11):951-960. doi: 10.1016/j.jchf.2018.07.012.

PMID:
30384913
25.

Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy.

Garan AR, Malick WA, Habal M, Topkara VK, Fried J, Masoumi A, Hasan AK, Karmpaliotis D, Kirtane A, Yuzefpolskaya M, Farr M, Naka Y, Burkhoff D, Colombo PC, Kurlansky P, Takayama H, Takeda K.

ASAIO J. 2018 Oct 9. doi: 10.1097/MAT.0000000000000898. [Epub ahead of print]

PMID:
30312208
26.

A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial.

Mehra MR, Salerno C, Naka Y, Uriel N, Cleveland JC, Horstmanshof D, Goldstein DJ; MOMENTUM 3 Investigators.

J Heart Lung Transplant. 2018 Nov;37(11):1281-1284. doi: 10.1016/j.healun.2018.08.011. Epub 2018 Aug 24. No abstract available.

PMID:
30245150
27.

Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices.

Fried J, Garan AR, Shames S, Masoumi A, Yuzefpolskaya M, Takeda K, Takayama H, Uriel N, Naka Y, Colombo PC, Topkara VK.

J Heart Lung Transplant. 2018 Dec;37(12):1425-1432. doi: 10.1016/j.healun.2018.07.012. Epub 2018 Jul 25.

PMID:
30241886
28.

Conduction Abnormalities Associated with Tricuspid Annuloplasty in Cardiac Transplantation.

Rubin G, Sanchez J, Bayne J, Avula UMR, Takayama H, Takeda K, Naka Y, Garan H, Farr MA, Wan EY.

ASAIO J. 2018 Sep 17. doi: 10.1097/MAT.0000000000000873. [Epub ahead of print]

PMID:
30234504
29.

Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.

Truby LK, Takeda K, Topkara VK, Takayama H, Garan AR, Yuzefpolskaya M, Colombo P, Naka Y, Farr M.

J Heart Lung Transplant. 2018 Dec;37(12):1433-1442. doi: 10.1016/j.healun.2018.07.013. Epub 2018 Jul 26.

PMID:
30206023
30.

Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.

Castillero E, Ali ZA, Akashi H, Giangreco N, Wang C, Stöhr EJ, Ji R, Zhang X, Kheysin N, Park JS, Hegde S, Patel S, Stein S, Cuenca C, Leung D, Homma S, Tatonetti NP, Topkara VK, Takeda K, Colombo PC, Naka Y, Sweeney HL, Schulze PC, George I.

Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1463-H1476. doi: 10.1152/ajpheart.00187.2018. Epub 2018 Aug 24.

PMID:
30141986
31.

Impact of Sharing O Heart With Non-O Recipients: Simulation in the United Network for Organ Sharing Registry.

Ando M, Takeda K, Kurlansky PA, Han J, Garan AR, Topkara VK, Yuzefpolskaya M, Colombo PC, Farr M, Naka Y, Takayama H.

Ann Thorac Surg. 2018 Nov;106(5):1356-1363. doi: 10.1016/j.athoracsur.2018.06.039. Epub 2018 Aug 1.

PMID:
30076793
32.

Increase in antinuclear antibody levels through biologic treatment for psoriasis.

Miki M, Endo C, Naka Y, Fukuya Y, Kobayashi S, Kawashima M, Tsunemi Y.

J Dermatol. 2019 Feb;46(2):e50-e51. doi: 10.1111/1346-8138.14578. Epub 2018 Jul 27. No abstract available.

PMID:
30051919
33.

Gene cloning, expression, and X-ray crystallographic analysis of a β-mannanase from Eisenia fetida.

Ueda M, Hirano Y, Fukuhara H, Naka Y, Nakazawa M, Sakamoto T, Ogata Y, Tamada T.

Enzyme Microb Technol. 2018 Oct;117:15-22. doi: 10.1016/j.enzmictec.2018.05.014. Epub 2018 May 25.

PMID:
30037547
34.

VA-ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted?

Habal MV, Truby L, Ando M, Ikegami H, Garan AR, Topkara VK, Colombo P, Takeda K, Takayama H, Naka Y, Farr MA.

Clin Transplant. 2018 Sep;32(9):e13356. doi: 10.1111/ctr.13356. Epub 2018 Aug 13.

PMID:
30035809
35.

Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist Device.

Nakanishi K, Homma S, Han J, Takayama H, Colombo PC, Yuzefpolskaya M, Garan AR, Farr MA, Kurlansky P, Di Tullio MR, Naka Y, Takeda K.

J Am Heart Assoc. 2018 Jun 24;7(13). pii: e008813. doi: 10.1161/JAHA.118.008813.

36.

End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.

Nakagawa S, Garan AR, Takayama H, Takeda K, Topkara VK, Yuzefpolskaya M, Lin SX, Colombo PC, Naka Y, Blinderman CD.

J Palliat Med. 2018 Sep;21(9):1284-1289. doi: 10.1089/jpm.2018.0112. Epub 2018 Jun 6.

PMID:
29874117
37.

EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device.

Akanni OJ, Takeda K, Truby LK, Kurlansky PA, Chiuzan C, Han J, Topkara VK, Yuzefpolskaya M, Colombo PC, Karmpaliotis D, Moses JW, Naka Y, Garan AR, Kirtane AJ, Takayama H.

ASAIO J. 2019 Mar/Apr;65(3):219-226. doi: 10.1097/MAT.0000000000000804.

PMID:
29734259
38.

Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients.

Truby LK, Sridharan L, Flores RJ, Garan AR, Jennings D, Yuzefpolskaya M, Takeda K, Takayama H, Naka Y, Colombo PC, Topkara VK.

ASAIO J. 2019 Mar/Apr;65(3):233-240. doi: 10.1097/MAT.0000000000000803.

PMID:
29734258
39.

Molecular Design for Preparation of Hexagonal-Ordered Porous Films Based on Side-Chain-Type Liquid-Crystalline Star Polymer.

Naka Y, Takayama H, Koyama T, Le KV, Sasaki T.

Langmuir. 2018 May 29;34(21):6210-6216. doi: 10.1021/acs.langmuir.8b01104. Epub 2018 May 16.

PMID:
29716189
40.

Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.

Fried JA, Nair A, Takeda K, Clerkin K, Topkara VK, Masoumi A, Yuzefpolskaya M, Takayama H, Naka Y, Burkhoff D, Kirtane A, Karmpaliotis D, Moses J, Colombo PC, Garan AR.

J Heart Lung Transplant. 2018 Nov;37(11):1313-1321. doi: 10.1016/j.healun.2018.03.011. Epub 2018 Mar 20.

PMID:
29678608
41.

Usefulness of Tricuspid Annular Diameter to Predict Late Right Sided Heart Failure in Patients With Left Ventricular Assist Device.

Nakanishi K, Homma S, Han J, Takayama H, Colombo PC, Yuzefpolskaya M, Garan AR, Farr MA, Kurlansky P, Di Tullio MR, Naka Y, Takeda K.

Am J Cardiol. 2018 Jul 1;122(1):115-120. doi: 10.1016/j.amjcard.2018.03.010. Epub 2018 Mar 28.

PMID:
29673504
42.

Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.

Truby LK, Garan AR, Givens RC, Takeda K, Takayama H, Trinh PN, Yuzefpolskaya M, Farr MA, Naka Y, Colombo PC, Topkara VK.

Circ Heart Fail. 2018 Apr;11(4):e004586. doi: 10.1161/CIRCHEARTFAILURE.117.004586.

43.

Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.

Sridharan L, Wayda B, Truby LK, Latif F, Restaino S, Takeda K, Takayama H, Naka Y, Colombo PC, Maurer M, Farr MA, Topkara VK.

Circ Heart Fail. 2018 Mar;11(3):e004665. doi: 10.1161/CIRCHEARTFAILURE.117.004665.

44.

Socioeconomic Disparities in Adherence and Outcomes After Heart Transplant: A UNOS (United Network for Organ Sharing) Registry Analysis.

Wayda B, Clemons A, Givens RC, Takeda K, Takayama H, Latif F, Restaino S, Naka Y, Farr MA, Colombo PC, Topkara VK.

Circ Heart Fail. 2018 Mar;11(3):e004173. doi: 10.1161/CIRCHEARTFAILURE.117.004173.

PMID:
29664403
45.

Late outcomes of subcostal exchange of the HeartMate II left ventricular assist device: a word of caution.

Yu SN, Takayama H, Han J, Garan AR, Kurlansky P, Yuzefpolskaya M, Colombo PC, Naka Y, Takeda K.

Eur J Cardiothorac Surg. 2018 Oct 1;54(4):652-656. doi: 10.1093/ejcts/ezy159.

PMID:
29648627
46.

Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis.

Jennings DL, Lange N, Shullo M, Latif F, Restaino S, Topkara VK, Takeda K, Takayama H, Naka Y, Farr M, Colombo P, Baker WL.

Int J Cardiol. 2018 Aug 15;265:71-76. doi: 10.1016/j.ijcard.2018.03.111. Epub 2018 Mar 24.

PMID:
29605470
47.

Role of computed tomography angiography for HeartMate II left ventricular assist device thrombosis.

Yu SN, Han J, Takeda K, Ginns JN, Kurlansky PA, Garan AR, Yuzefpolskaya M, Topkara VK, Colombo PC, Naka Y, Takayama H.

Int J Artif Organs. 2018 Jun;41(6):325-332. doi: 10.1177/0391398818762354. Epub 2018 Mar 21.

PMID:
29562790
48.

Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.

Mehra MR, Goldstein DJ, Uriel N, Cleveland JC Jr, Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, Itoh A, Dean D, Krishnamoorthy A, Cotts WG, Tatooles AJ, Jorde UP, Bruckner BA, Estep JD, Jeevanandam V, Sayer G, Horstmanshof D, Long JW, Gulati S, Skipper ER, O'Connell JB, Heatley G, Sood P, Naka Y; MOMENTUM 3 Investigators.

N Engl J Med. 2018 Apr 12;378(15):1386-1395. doi: 10.1056/NEJMoa1800866. Epub 2018 Mar 11.

49.

Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score.

Birati EY, Hanff TC, Maldonado D, Grandin EW, Kennel PJ, Mazurek JA, Vorovich E, Seigerman M, Howard JLL, Acker MA, Naka Y, Wald J, Goldberg LR, Jessup M, Atluri P, Margulies KB, Schulze PC, Rame JE.

J Am Heart Assoc. 2018 Mar 7;7(6). pii: e006408. doi: 10.1161/JAHA.117.006408.

50.

A continuous-flow external ventricular assist device for cardiogenic shock: Evolution over 10 years.

Ando M, Garan AR, Takayama H, Topkara VK, Han J, Kurlansky P, Yuzefpolskaya M, Farr MA, Colombo PC, Naka Y, Takeda K.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):157-165.e1. doi: 10.1016/j.jtcvs.2017.12.148. Epub 2018 Feb 13.

PMID:
29510941

Supplemental Content

Support Center